SCHEMBL8324517

SCHEMBL8324517

CCCNC(=O)c1ccc(OC)c(F)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 1/20 0.65
TAS1R1 Q7RTX1 1/20 0.65
MEN1 O00255 1/20 0.62
KMT2A Q03164 1/20 0.62
ROCK2 O75116 1/20 0.60
RAB9A P51151 3/20 0.58
LMNA P02545 1/20 0.58
MAPK1 P28482 1/20 0.58
HTT P42858 1/20 0.58
TP53 P04637 1/20 0.56
NPC1 O15118 2/20 0.53
SMPD1 P17405 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
TMEM97 Q5BJF2 1/20 0.52
SIGMAR1 Q99720 1/20 0.52
CD274 Q9NZQ7 1/20 0.52
POLB P06746 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.50
KCNQ3 O43525 1/20 0.50
KCNQ2 O43526 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6356980 0.92 MEN1 (0.67) TAS1R3TAS1R1MEN1KMT2AROCK2
SCHEMBL11755664 0.88 MEN1 (0.70) TAS1R3TAS1R1MEN1KMT2ARAB9A
SCHEMBL930908 0.86 ROCK2 (0.76) MEN1KMT2AROCK2RAB9AHTT
SCHEMBL14340547 0.84 TAS1R3 (0.64) TAS1R3TAS1R1MEN1KMT2AROCK2
SCHEMBL17758484 0.84 ROCK2 (0.61) MEN1KMT2AROCK2RAB9AHTT
SCHEMBL12988882 0.83 L3MBTL1 (0.57) KMT2ASMN1; SMN2POLBL3MBTL1
SCHEMBL26446035 0.82 TAS1R3 (0.49) TAS1R3TAS1R1MEN1KMT2AROCK2
SCHEMBL8324748 0.82 TAS1R3 (0.64) TAS1R3TAS1R1MEN1KMT2AROCK2
SCHEMBL6582492 0.81 HTT (0.65) TAS1R3TAS1R1MEN1KMT2ARAB9A
SCHEMBL30622701 0.81 HTT (0.65) TAS1R3TAS1R1MEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1592426-B1 2-CYANOPYRROLOPYRIMIDINES AND PHARMACEUTICAL USES THEREOF NOVARTIS AG (CH) 2007-12-19 EP disclosed
WO-2004069256-A1 2-CYANOPYRROLOPYRIMIDINES AND PHARMACEUTICAL USES THEREOF NOVARTIS AG (CH) 2004-08-19 WO disclosed